Creatine kinase enzyme is carbonylated in the quadriceps of COPD patients

E. Barreiro, J. Gea, E. Melo, S. N. Hussain (Barcelona, Spain; Montreal, Canada)

Source: Annual Congress 2005 - Skeletal muscles: current concepts
Session: Skeletal muscles: current concepts
Session type: Oral Presentation
Number: 1668
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Increased protein carbonylation has been shown in quadriceps of COPD patients. Our aim was to assess whether creatine kinase (CK) is carbonylated and whether the degree of carbonylation influences its activity in quadriceps of COPD patients. Methods: Quadriceps biopsies were obtained from 6 normal subjects and 12 COPD patients. Protein carbonylation intensity and identification of carbonylated proteins was achieved using the Oxyblot kit, 2D electrophoresis, and Mass Spectrometry analysis. CK expression and activity were also measured. Results: CK protein expression and activity were significantly higher in quadriceps of COPD patients compared with controls. Both muscle CK and carbonic anyhdrase III (CAIII) were the most intensely carbonylated proteins in both controls and COPD patients. Within COPD patients, muscle CK protein levels and activity positively correlated with FEV1 (% pred.) (r=0.82,** and r=0.66,*, respectively), while muscle CK carbonylation intensity did it negatively (r=0.88, *). Furthermore, CK activity negatively correlated with muscle CK carbonylation intensity. Conclusions: Peripheral muscles of COPD patients undergo adaptation by increasing CK protein expression and activity, and both CK and CAIII appear to be important targets for protein carbonylation in those muscles.
Funded by: Enigma in COPD QLRT-2002-02285 (EU), RESPIRA (RTIC C03/11).


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Barreiro, J. Gea, E. Melo, S. N. Hussain (Barcelona, Spain; Montreal, Canada). Creatine kinase enzyme is carbonylated in the quadriceps of COPD patients. Eur Respir J 2005; 26: Suppl. 49, 1668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Protein oxidation in the diaphragm of patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 358s
Year: 2003

Lactate dehydrogenase isozymes in skeletal muscle of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 160s
Year: 2006

Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD
Source: Eur Respir J 2013; 41: 1275-1283
Year: 2013



Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 17: 939-945
Year: 2001



Glutamate and glutathione levels are preserved in the diaphragm of patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 18s
Year: 2002

Effects of exercise on ubiquitination and proteasome activity in skeletal muscle in COPD patients
Source: Annual Congress 2012 - Exercise testing in disease
Year: 2012

Association between creatine kinase level and mortality in high-risk patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Expression and functional significance of nicotinamide N-methyltransferase (NNMT) in quadriceps and diaphragm of patients with COPD
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008

Uncoupling protein 3 content is decreased in skeletal muscle of patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 88s
Year: 2002

Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015

Reduced mitochondrial density in the quadriceps muscle of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 621s
Year: 2006

Quadriceps myostatin expression in COPD
Source: Eur Respir J 2010; 36: 686-688
Year: 2010



Validation of AMP-activated protein kinase as a therapeutic target in bronchiectasis
Source: ERS Lung Science Conference 2020
Year: 2020

Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Source: Eur Respir J 2013; 42: 28-41
Year: 2013



Metabolic stress during exercise in the skeletal muscles of COPD patients
Source: Annual Congress 2003 - Exercise in COPD
Year: 2003


Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

NF-κB and AP-1 activation in the quadriceps of COPD patients
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010

Impaired skeletal muscle kynurenine metabolism in patients with COPD
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Vastus lateralis proteomic analysis in muscle wasted patients with COPD
Source: Annual Congress 2013 –The best abstracts in physical inactivity and exercise training in COPD
Year: 2013



Antioxidant enzyme increase following magnetic stimulation training in the quadriceps of patients with severe COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 727s
Year: 2007